Latest 10-Q quarterly reports

SilverBox Corp IV reports Q1 2026 net income of $1.37 million while continuing to pursue its business combination with Parataxis Holdings.

Allarity Therapeutics reports Q1 2026 financial results, highlighting a $20 million capital raise and continued development of its stenoparib drug candidate.

SoundThinking reported a net loss of $7.0 million for Q1 2026, driven by a 15% revenue decline compared to the same period last year.

Chain Bridge I reports a net loss of $436,659 for Q1 2026 while continuing to pursue a business combination with Phytanix Bio.

Vaso Corporation reports a net loss of $0.89 million for Q1 2026, reflecting ongoing operational shifts and segment performance variations.

IGC Pharma reports Q1 2026 financial results, highlighting progress in its Phase 2 CALMA clinical trial for IGC-AD1 and ongoing AI platform development.

Fifth Era Acquisition Corp I has entered into a definitive business combination agreement with Miotal, a strategic metals platform, valued at $10 billion.

Latch, Inc. reported a reduced net loss of $5.9 million for Q1 2026 and announced a new $5.0 million revolving credit facility.

Nuwellis reports Q1 2026 revenue growth of 26.2% alongside the acquisition of Rendiatech to expand its cardiorenal platform.

National Presto Industries reports a 13% decline in net earnings for Q1 2026, driven by startup challenges in its housewares segment despite strong defense sector growth.

American Strategic Investment Co. reports a net loss of $7.8 million for Q1 2026 amid ongoing debt defaults and foreclosure proceedings.

ENDRA Life Sciences reports a net loss of $1.3 million for Q1 2026 while facing Nasdaq delisting risks due to equity deficiencies.

Innovative Payment Solutions reports no revenue for Q1 2026 while navigating significant debt defaults and restructuring.

Research Solutions reports Q3 2026 net income of $0.86 million, driven by platform growth and reduced operating expenses.

Broadway Financial Corporation reports a return to profitability in Q1 2026 with $1.16 million in net income compared to a loss in the prior year period.

ADM Endeavors reports a net loss of $132,074 for Q1 2026 despite a 10.6% increase in total revenue to $1.02 million.

Regional Health Properties reports Q1 2026 financial results, highlighting a transition toward an integrated owner-operator model and the impact of the SunLink merger.

Yale Transaction Finders reports a net loss of $8,764 for Q1 2026 as it continues to operate as a shell company seeking a business combination.

Aldabra 4 Liquidity Opportunity Vehicle, Inc. reports its first quarterly financial results following its January 2026 IPO, maintaining a trust account of over $302 million.

United Health Products reports zero revenue for Q1 2026 as it continues to focus on FDA Premarket Approval for its CelluSTAT hemostatic gauze.

Lion Copper and Gold Corp. reports Q1 2026 financial results, highlighting $30.5 million in new funding from Nuton LLC to advance the Yerington Copper Project.

Mobiquity Technologies reports Q1 2026 net loss of $2.5 million while highlighting ongoing efforts to expand its programmatic advertising and AI-driven marketing platforms.

Moveix Inc. reports no revenue and a net loss of $26,076 for the first quarter of 2026 as it continues to operate as a shell company.

China Foods Holdings reports a net loss of $61,597 for the first quarter of 2026, supported by ongoing financial backing from its controlling shareholder.

International Land Alliance reports a net loss of $2.7 million for Q1 2026 amid ongoing liquidity challenges and substantial doubt regarding its ability to continue as a going concern.

MicroVision reports Q1 2026 results, highlighting strategic acquisitions of lidar assets and ongoing efforts to reduce operating expenses.

Premier Air Charter Holdings reports Q1 2026 revenue growth to $7.2 million while maintaining a going concern warning.

Luvu Brands reported a net income of $174,000 for the third quarter of fiscal 2026, driven by a 12% increase in quarterly net sales.

CyberloQ Technologies reports a net loss of $234,060 for Q1 2026 as it continues development of its fraud prevention platform.

KALA BIO reports Q1 2026 financial results while transitioning from a clinical-stage biopharmaceutical company to an AI platform-as-a-service provider.